Boston Scientific director buys 2,100 shares

Boston Scientific director David C. Habiger purchased 2,100 shares of common stock on August 5, 2026 in an open-market transaction at a weighted average price of $47.589 per share, with individual trade prices between $47.21 and $47.98.

Accepted by SEC EDGAR 08/07/2026 - 04:16 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Boston Scientific director David C. Habiger purchased 2,100 shares of common stock on August 5, 2026 in an open-market transaction at a weighted average price of $47.589 per share, with individual trade prices between $47.21 and $47.98. Following this purchase, he directly owns 17,160 shares.

Insider Trade Summary

Net Buyer: 2,100 shares

Net Buy 1 txn

Insider Habiger David C

Role Director

Bought 2,100 shs ($100K)

Increase in Position 13.9%

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	2,100	$47.589	$100K

Holdings After Transaction: Common Stock — 17,160 shares (Direct)

Holdings Before and After: Common Stock, 15,060 to 17,160 shares (Direct)

Other Insiders: 2 other insiders reported open-market purchases of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Key Figures

Shares purchased: 2,100 shares Weighted average price: $47.589 per share Purchase price range low: $47.21 per share +3 more

6 metrics

Shares purchased 2,100 shares Common Stock acquired on August 5, 2026

Weighted average price $47.589 per share Average purchase price for the 2,100 shares

Purchase price range low $47.21 per share Lowest price among multiple purchase transactions

Purchase price range high $47.98 per share Highest price among multiple purchase transactions

Shares owned after transaction 17,160 shares Direct holdings of Common Stock following the purchase

Net shares bought 2,100 shares Net buy reported in this Form 4

Key Terms

weighted average purchase price, open market or private transaction

2 terms

weighted average purchase price financial

"Represents the weighted average purchase price. These shares were purchased..."

The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.

open market or private transaction financial

"transaction code description: Purchase in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Boston Scientific (BSX) director David C. Habiger report?

David C. Habiger reported a purchase of 2,100 shares of Boston Scientific common stock on August 5, 2026. The transaction was reported as a director-level open-market trade in the company’s common stock.

How many Boston Scientific (BSX) shares did Habiger buy and at what price?

Habiger bought 2,100 BSX shares at a weighted average price of $47.589 per share. The footnote explains these were multiple trades executed between $47.21 and $47.98 per share.

What are David C. Habiger’s Boston Scientific (BSX) holdings after this purchase?

After the reported purchase, Habiger directly holds 17,160 shares of Boston Scientific common stock. This figure reflects his ownership immediately following the August 5, 2026 open-market acquisition of 2,100 additional shares.

Was Habiger’s Boston Scientific (BSX) trade an open-market purchase?

Yes. The Form 4 classifies the transaction with code P, described as a “Purchase in open market or private transaction”. The accompanying data show it as a direct ownership, non-derivative acquisition of common stock.

Over what price range were the Boston Scientific (BSX) shares purchased by Habiger?

The filing notes a weighted average purchase price of $47.589, with individual trades executed at prices ranging from $47.21 to $47.98 per share. The insider offers to provide detailed trade-by-trade pricing information upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Habiger David C

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		P		2,100	A	$47.589(1)	17,160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Susan Thompson, Attorney-in-Fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)